Dipna Pharmachem Stock Screener | Share Price & Fundamental Analysis
DPL
Pharmaceuticals
Screen Dipna Pharmachem share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹43.36 Cr.
P/B Ratio
1.05
EPS (TTM)
₹0.41
Dividend Yield
-
Debt to Equity
0.48
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹132.00
Total Equity
₹39.00
Dipna Pharmachem Share Price History - Stock Screener Chart
Screen DPL historical share price movements with interactive charts. Analyze price trends and patterns.
Dipna Pharmachem Company Profile - Fundamental Screener
Screen Dipna Pharmachem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DPL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0MC401013
Dipna Pharmachem Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen DPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 132 | 133 | 78 | 36 | 25 | 18 | 14 | 11 |
| Current Assets | 132 | 133 | 78 | 36 | 25 | 18 | 14 | 11 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||
| Total Liabilities | 132 | 133 | 78 | 36 | 25 | 18 | 14 | 11 |
| Current Liabilities | 9 | 13 | 11 | 6 | 4 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 39 | 38 | 24 | 2 | 1 | 1 | 1 | 1 |
| Share Capital | 24 | 24 | 12 | 0 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 14 | 14 | 12 | 2 | 1 | 1 | 1 | 0 |
Screen DPL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 125 | 164 | 100 | 73 | 31 | 31 | 20 | 17 |
| Expenses | 0 | 122 | 161 | 98 | 71 | 31 | 31 | 20 | 17 |
| EBITDA | 0 | 3 | 3 | 2 | 2 | 0 | 0 | 0 | 0 |
| Operating Profit % | 0.00% | 3.00% | 2.00% | 2.00% | 3.00% | 1.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| EPS | 0.00 | 0.41 | 0.45 | 0.76 | 333.39 | 6.91 | 16.86 | 9.15 | 17.27 |
Dipna Pharmachem Cash Flow Screener - Liquidity Fundamentals
Screen DPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | -9 | -5 | -21 | 3 | -2 | -3 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | -4 | 14 | 27 | -3 | 3 | 3 |
| Net Cash Flow | -13 | 8 | 6 | 0 | 0 | 0 |
Screen DPL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Sept | 2025-Nov | 2024-Mar | 2024-Sept | 2023-Mar | 2023-Sept | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 9.98% | 9.98% | 9.13% | 9.98% | 9.98% | 66.56% | 57.19% | 9.98% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 71.21% | 73.74% | 79.11% | 63.07% | 81.82% | 31.36% | 40.33% | 63.07% |
| Other Holding | 18.81% | 16.28% | 11.76% | 26.95% | 8.20% | 2.08% | 2.48% | 26.95% |
| Shareholder Count | 1,997 | 1,742 | 1,741 | 1,807 | 2,652 | 992 | 1,078 | 1,807 |
Dipna Pharmachem Dividend Screener - Share Yield Analysis
Screen DPL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Dipna Pharmachem Index Membership - Market Screener Classification
Screen DPL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Dipna Pharmachem Market Events Screener - Corporate Actions
Screen DPL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-26 | 2025-11-26 | Quarterly Result Announcement | NA | -10.55% |
| 2025-08-30 | 2025-08-30 | Annual General Meeting | NA | -5.94% |
| 2025-07-07 | 2025-07-07 | Quarterly Result Announcement | NA | 3.65% |
| 2025-04-04 | 2025-04-04 | Extraordinary General Meeting | NA | 10.31% |
| 2024-12-11 | 2024-12-11 | Quarterly Result Announcement | NA | 0.00% |
| 2024-08-27 | 2024-08-27 | Annual General Meeting | NA | 15.01% |
| 2024-02-12 | 2024-02-12 | Rights | 13:12 | 27.52% |
| 2024-01-03 | 2024-01-03 | Extraordinary General Meeting | NA | -10.98% |
Dipna Pharmachem Competitors Screener - Peer Comparison
Screen DPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Dipna Pharmachem Company Announcements - News Screener
Screen DPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-29 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-11-29 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday 29Th November 2025 | View |
| 2025-11-26 | Statement Of Deviation And Variation | View |
| 2025-11-26 | Integrated Filing (Financial) For The Half Year Ended On 30Th September 2025 | View |
| 2025-11-26 | Unaudited Financial Results For The Half Year Ended On 30Th September 2025. | View |
| 2025-11-26 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Wednesday 26Th November 2025 | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-11-19 | Board Meeting Intimation for Intimation Of Rescheduling Of Board Meeting | View |
| 2025-11-14 | Board Meeting Intimation for Intimation Of Rescheduling Of Board Meeting | View |
| 2025-11-10 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday 14Th November 2025 | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Closure of Trading Window | View |
| 2025-09-12 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-09-09 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Tuesday 9Th September 2025 | View |
| 2025-09-01 | Voting Results Of The Annual General Meeting | View |
| 2025-09-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-08-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-30 | Intimation Of In-Principle Approval For Issue Of 76605000 Warrants Convertible Into Equity Shares Of M/S. Dipna Pharmachem Limited (The Company) Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requireme | View |
| 2025-08-28 | Undertaking Regarding Appointment Of Monitoring Agency - Preferential Issue Of Equity Shares | View |
| 2025-08-08 | Intimation Of Book Closure Pursuant To Regulation 42 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation 2015 | View |